Researcher.Life Logo

JOURNAL OF HEPATOCELLULAR CARCINOMA : Impact Factor & More

eISSN: 2253-5969pISSN: 2253-5969
JournalOpen Access

Key Metrics

Eigenfactor
< 0.001
Impact Factor
< 5
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on JOURNAL OF HEPATOCELLULAR CARCINOMA

JOURNAL OF HEPATOCELLULAR CARCINOMA Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DOVE MEDICAL PRESS LTD
Language English
Frequency Continuous publication
Article Processing ChargesUSD 2836
Publication Time16
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year2014
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 16
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC
OA statementVisit website
View less

Planning to publish in JOURNAL OF HEPATOCELLULAR CARCINOMA ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in JOURNAL OF HEPATOCELLULAR CARCINOMA

Identification of a Prognostic Gene Signature Based on Lenvatinib Resistance in Hepatocellular Carcinoma with Functional Validation of the Key Gene CPB2
  • 14 May 2026
  • Journal of Hepatocellular Carcinoma
USP9X Promotes Hepatocellular Carcinoma Progression via Stabilization of HSP90AA1
  • 12 May 2026
  • Journal of Hepatocellular Carcinoma
A Reproducible MRI-Based Quantitative Feature for Differentiating Dysplastic Nodules from Hepatocellular Carcinoma: A Multicenter Retrospective Study
  • 12 May 2026
  • Journal of Hepatocellular Carcinoma
Liver Transplantation After Radiotherapy-Antiangiogenesis-Immune Checkpoint Blockade Combination Therapy in Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Propensity Score Matching Analysis
  • 8 May 2026
  • Journal of Hepatocellular Carcinoma
ADAM12 Stabilizes EIF3B to Promote Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
  • 1 May 2026
  • Journal of hepatocellular carcinoma
GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway.
  • 1 May 2026
  • Journal of hepatocellular carcinoma
Identification of a Prognostic Gene Signature Based on Lenvatinib Resistance in Hepatocellular Carcinoma with Functional Validation of the Key Gene CPB2
  • 14 May 2026
  • Journal of Hepatocellular Carcinoma
USP9X Promotes Hepatocellular Carcinoma Progression via Stabilization of HSP90AA1
  • 12 May 2026
  • Journal of Hepatocellular Carcinoma
A Reproducible MRI-Based Quantitative Feature for Differentiating Dysplastic Nodules from Hepatocellular Carcinoma: A Multicenter Retrospective Study
  • 12 May 2026
  • Journal of Hepatocellular Carcinoma
Liver Transplantation After Radiotherapy-Antiangiogenesis-Immune Checkpoint Blockade Combination Therapy in Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Propensity Score Matching Analysis
  • 8 May 2026
  • Journal of Hepatocellular Carcinoma
ADAM12 Stabilizes EIF3B to Promote Glycolysis and Tumor Progression in Hepatocellular Carcinoma.
  • 1 May 2026
  • Journal of hepatocellular carcinoma
GRB2 Promotes Sorafenib Resistance in Hepatocellular Carcinoma Cells Under Hypoxia by Activating the PI3K/AKT Signaling Pathway.
  • 1 May 2026
  • Journal of hepatocellular carcinoma

FAQs on JOURNAL OF HEPATOCELLULAR CARCINOMA